Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Spectrila

This product is the most expensive of its product family


Contraindicated
Lack of data in pregnant women

Not recommended
Lack of data
Spectrila :
Type Medicine Authorised
Originator Biotech (Kidrolase)
Agent Alfamed
Distributor Alfamed
Laboratory Medac
Responsible Party Medac Gesellschaft Fur Klinische Spezialpraparate
Origin Germany
Manufacturer Medac Gesellschaft
Manufacturing Type G
Origin Germany
ATC L01XX02

Your comment will appear shortly after approval

Spectrila :

Revision Date : 27/04/2017


Effect Frequency
Abdominal pain Common
Activated partial thromboplastin time prolonged Very Common
ALT increased Common
Amenorrhoea (amenorrhea) Not known
Anaemia Not known
Anaphylactic reactions Very Common
Anaphylactic shock Not known
Antithrombin III decreased Very Common
Arterial thrombotic events Common
AST increased Common
Azoospermia Not known
Blood bilirubin increased Common
Bone marrow failure (Myelosuppression) Not known
Bronchospasm Very Common
Chills Common
Coagulation disorders Very Common
Coagulation factor IX level abnormal Very Common
Coagulation factor VII level abnormal Very Common
Coagulation factor VIII level abnormal Very Common
Coagulation factor X level abnormal Very Common
Coma Not known
Confusional state Not known
Cytolytic hepatitis Not known
Diabetic ketoacidosis Not known
Diarrhoea (Diarrhea) Common
Dyspnoea (dyspnea) Very Common
Erythema Very Common
Face oedema Very Common
Fatigue Not known
Febrile neutropenia (Neutropenic fever) Not known
Fever Common
Fibrinogen decreased Very Common
Flushing Not known
Gamma-GT increased Common
Haemorrhage Not known
Hepatic failure (Hepatic insufficiency) (Liver failure) Rare
Hepatic steatosis Not known
Hepatitis cholestatic Not known
Hepatomegaly Not known
Hyperammonaemia Not known
Hyperamylasaemia Common
Hypercholesterolaemia Not known
Hyperglycaemia Common
Hyperinsulinism Common
Hypertension Not known
Hypertriglyceridaemia Common
Hypoalbuminaemia Not known
Hypotension Very Common
Infection Not known
Injection site erythema Not known
Injection site haematoma Not known
Injection site oedema Not known
Injection site pain Not known
Laryngeal oedema Very Common
Leucopenia (Leukopenia) Not known
Lip swelling Very Common
Lipase increased Common
Malaise Not known
Metabolic encephalopathy Not known
Myocardial infarction Not known
Nausea Very Common
Necrotizing pancreatitis Very rare
Neutropenia Not known
Oedema peripheral Common
Pain Common
Pancreatitis Not known
Pancreatitis acute Common
Pancreatitis haemorrhagic Very rare
Phosphatase alkaline increased Common
Plasminogen decreased Very Common
Posterior reversible leukoencephalopathy syndrome (PRES) Rare
Protein C decreased Very Common
Protein S decreased Very Common
Prothrombin time prolonged Very Common
Pruritus Very Common
Renal insufficiency Not known
Sepsis (Systemic infection) (Sepsis state) Not known
Stupor Not known
Thrombocytopenia (Thrombopenia) Not known
Urticaria Very Common
Venous thromboembolic event Common
Vomiting Very Common

Different Units By MoH Code

Spectrila  MoH 9300 :
Form Powder for concentrate for solution for infusion
Packaging Bottle
Package Size 1+1x2.5ml
Strength 10000IU
Public Price 21370812.65 L.L.
Stratum D
NSSF ✘
Quarantine ✘
Reg. Number 60417/1
Submission date 05/02/2017
Registration Year 20/06/2017


Price Comparison

● Country: Germany
● Package Size: 1+1x2,5ml
● Public Price: 750.17 EUR ( 72,673,468.92 LBP )
● Pack size unit used: 1
● Cost/Unit: 750,17 EUR ( 72,657,000.00 LBP )
● Pricing Date: 24/10/2020
● Type: Medicine Authorised

● Country: Abu Dhabi
● Package Size: 1 Vial
● Public Price: 2467.5 AED ( 59,617,267.50 LBP )
● Pack size unit used: 1
● Cost/Unit: 2467,5 AED ( 59,605,187.00 LBP )
● Pharmacy Price: 2102.23 AED ( 50791979.03 LBP )
● Pricing Date: 27/01/2021
● Type: Medicine Authorised

● Country: UAE
● Package Size: 1 Glass Vial
● Public Price: 2467.5 AED ( 59,617,267.50 LBP )
● Pack size unit used: 1
● Cost/Unit: 2467,5 AED ( 59,605,187.00 LBP )
● Pharmacy Price: 2102.23 AED ( 50791979.03 LBP )
● Pricing Date: 21/08/2019
● Type: Medicine Authorised

● Country: UK
● Package Size: 1
● Public Price: 450 GBP ( 51,142,050.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 450 GBP ( 51,142,050.00 LBP )
● Reference: DMD
● Pricing Date: 08/03/2021
● Type: Medicine Withdrawn

● Country: The Netherlands
● Package Size: 1
● Public Price: 464.69 EUR ( 45,017,308.44 LBP )
● Pack size unit used: 1
● Cost/Unit: 464,69 EUR ( 44,950,464.00 LBP )
● Pharmacy Price: 457.69 EUR ( 44339176.44 LBP )
● Reference: Zorginstituut Nederland
● Pricing Date: 15/06/2019
● Type: Medicine Authorised

● Country: Czech Republic
● Package Size: 1
● Public Price: 10156.64 CZK ( 38,788,208.16 LBP )
● Pack size unit used: 1
● Cost/Unit: 10156,64 CZK ( 38,785,764.00 LBP )
● Reference: SUKL
● Pricing Date: 28/02/2020
● Type: Medicine Authorised

● Country: Lebanon
● Form: Powder for concentrate for solution for infusion
● Package Size: 1+1x2.5ml
● Public Price: 21370812.65 LBP ( 21,370,812.65 LBP )
● Pack size unit used: 1
● Cost/Unit: 21370812,65 LBP ( 21,370,812.00 LBP )
● Pricing Date: 13/06/2024

● Country: France
● Package Size: 1
● Reference: ansm
● Pricing Date: 15/05/2021
● Type: Medicine Authorised

● Country: Finland
● Package Size: 1
● Reference: Kela
● Pricing Date: 22/04/2021
● Type: Medicine Non Marketed

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries

Note

Acute lymphoblastic leukaemia :
● Cost/Unit: 750,17 EUR ( 72,657,000.00 LBP )
● Cost/Day: 750,17 EUR ( 72,657,000.00 LBP )
● Cost/Month: 6001,36 EUR ( 581,352,876.00 LBP )
Leukaemic meningitis :
● Cost/Unit: 750,17 EUR ( 72,657,000.00 LBP )
● Cost/Day: 750,17 EUR ( 72,657,000.00 LBP )
● Cost/Month: 6001,36 EUR ( 581,352,876.00 LBP )
Non-Hodgkin’s lymphoma :
● Cost/Unit: 750,17 EUR ( 72,657,000.00 LBP )
● Cost/Day: 750,17 EUR ( 72,657,000.00 LBP )
● Cost/Month: 6001,36 EUR ( 581,352,876.00 LBP )
Acute lymphoblastic leukaemia :
● Cost/Unit: 2467,5 AED ( 59,605,187.00 LBP )
● Cost/Day: 2467,5 AED ( 59,605,187.00 LBP )
● Cost/Month: 19740 AED ( 476,938,140.00 LBP )
Leukaemic meningitis :
● Cost/Unit: 2467,5 AED ( 59,605,187.00 LBP )
● Cost/Day: 2467,5 AED ( 59,605,187.00 LBP )
● Cost/Month: 19740 AED ( 476,938,140.00 LBP )
Non-Hodgkin’s lymphoma :
● Cost/Unit: 2467,5 AED ( 59,605,187.00 LBP )
● Cost/Day: 2467,5 AED ( 59,605,187.00 LBP )
● Cost/Month: 19740 AED ( 476,938,140.00 LBP )
Acute lymphoblastic leukaemia :
● Cost/Unit: 2467,5 AED ( 59,605,187.00 LBP )
● Cost/Day: 2467,5 AED ( 59,605,187.00 LBP )
● Cost/Month: 19740 AED ( 476,938,140.00 LBP )
Leukaemic meningitis :
● Cost/Unit: 2467,5 AED ( 59,605,187.00 LBP )
● Cost/Day: 2467,5 AED ( 59,605,187.00 LBP )
● Cost/Month: 19740 AED ( 476,938,140.00 LBP )
Non-Hodgkin’s lymphoma :
● Cost/Unit: 2467,5 AED ( 59,605,187.00 LBP )
● Cost/Day: 2467,5 AED ( 59,605,187.00 LBP )
● Cost/Month: 19740 AED ( 476,938,140.00 LBP )
Acute lymphoblastic leukaemia :
● Cost/Unit: 450 GBP ( 51,142,050.00 LBP )
● Cost/Day: 450 GBP ( 51,142,050.00 LBP )
● Cost/Month: 3600 GBP ( 409,136,400.00 LBP )
Leukaemic meningitis :
● Cost/Unit: 450 GBP ( 51,142,050.00 LBP )
● Cost/Day: 450 GBP ( 51,142,050.00 LBP )
● Cost/Month: 3600 GBP ( 409,136,400.00 LBP )
Non-Hodgkin’s lymphoma :
● Cost/Unit: 450 GBP ( 51,142,050.00 LBP )
● Cost/Day: 450 GBP ( 51,142,050.00 LBP )
● Cost/Month: 3600 GBP ( 409,136,400.00 LBP )
Acute lymphoblastic leukaemia :
● Cost/Unit: 464,69 EUR ( 44,950,464.00 LBP )
● Cost/Day: 464,69 EUR ( 44,950,464.00 LBP )
● Cost/Month: 3717,52 EUR ( 360,088,092.00 LBP )
Leukaemic meningitis :
● Cost/Unit: 464,69 EUR ( 44,950,464.00 LBP )
● Cost/Day: 464,69 EUR ( 44,950,464.00 LBP )
● Cost/Month: 3717,52 EUR ( 360,088,092.00 LBP )
Non-Hodgkin’s lymphoma :
● Cost/Unit: 464,69 EUR ( 44,950,464.00 LBP )
● Cost/Day: 464,69 EUR ( 44,950,464.00 LBP )
● Cost/Month: 3717,52 EUR ( 360,088,092.00 LBP )
Acute lymphoblastic leukaemia :
● Cost/Unit: 10156,64 CZK ( 38,785,764.00 LBP )
● Cost/Day: 10156,64 CZK ( 38,785,764.00 LBP )
● Cost/Month: 81253,12 CZK ( 310,305,207.00 LBP )
Leukaemic meningitis :
● Cost/Unit: 10156,64 CZK ( 38,785,764.00 LBP )
● Cost/Day: 10156,64 CZK ( 38,785,764.00 LBP )
● Cost/Month: 81253,12 CZK ( 310,305,207.00 LBP )
Non-Hodgkin’s lymphoma :
● Cost/Unit: 10156,64 CZK ( 38,785,764.00 LBP )
● Cost/Day: 10156,64 CZK ( 38,785,764.00 LBP )
● Cost/Month: 81253,12 CZK ( 310,305,207.00 LBP )
Acute lymphoblastic leukaemia :
● Cost/Unit: 21370812,65 LBP ( 21,370,812.00 LBP )
● Cost/Day: 21370812,65 LBP ( 21,370,812.00 LBP )
● Cost/Month: 170966501,2 LBP ( 170,966,501.00 LBP )
Leukaemic meningitis :
● Cost/Unit: 21370812,65 LBP ( 21,370,812.00 LBP )
● Cost/Day: 21370812,65 LBP ( 21,370,812.00 LBP )
● Cost/Month: 170966501,2 LBP ( 170,966,501.00 LBP )
Non-Hodgkin’s lymphoma :
● Cost/Unit: 21370812,65 LBP ( 21,370,812.00 LBP )
● Cost/Day: 21370812,65 LBP ( 21,370,812.00 LBP )
● Cost/Month: 170966501,2 LBP ( 170,966,501.00 LBP )
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info